Pharmacokinetics and pharmacodynamics of hydromorphone hydrochloride in healthy horses.

The research article investigates how the drug hydromorphone, when administered via intravenous route (IV), behaves in the bodies of healthy horses and what effects it has on their physiology and behavior.

Methodology

• The experiment was set up with a cohort of six healthy, adult horses. The horses’ average weight was 585.2 ± 58.7 kg.
• These horses were administered three different treatments in a randomized order. The treatments included two doses of hydromorphone (0.025 mg/kg and 0.05 mg/kg) and a saline solution. A seven-day washout period allowed any remnants of previous treatments to leave the horses’ bodies before another treatment was administered.
• Over a period of five hours after giving the treatments, the researchers collected data on physiological and hematological variables, abdominal sounds (borborygmi) and the horses’ behavior. Fecal output over 24 hours was also recorded for each treatment.
• Blood samples collected from horses receiving the larger dose of hydromorphone were analyzed to determine the concentration of hydromorphone and its byproduct, hydromorphone-3-glucuronide, in the plasma. These data were used to calculate different pharmacokinetic parameters.

Results

• The administration of hydromorphone caused an increase in heart rate and systolic arterial pressure in the horses, with these effects being more pronounced with the higher hydromorphone dose.
• The researchers didn’t observe any significant changes in respiratory rate, arterial gases, or body temperature across the three treatments. Similarly, the volume of fecal output didn’t differ between treatments, and none of the horses showed signs of abdominal discomfort.
• The borborygmi scores decreased below baseline values for two hours after the administration of the hydromorphone treatments, indicating a reduction in gut activity.
• Pharmacokinetic parameters for the metabolite hydromorphone-3-glucuronide revealed that the body rapidly distributes and eliminates the drug.

Conclusions

• The research concluded that intravenously administered hydromorphone, while increasing heart rate and systolic arterial pressure, did not have observable effects on other vital signs or on fecal output in healthy horses.
• The drug also reduced abdominal borborygmi for a period, suggesting reduced gut activity, but without resulting in any apparent digestive problems or discomfort for the horses.